The lack of reduction in HMVEC E-selectin, the sLex ligand, further supports the one-sidedness of the finding and suggests that L-ASP modulates the permissiveness of the tumour microenvironment, a hypothesis that may apply also to ALL in the bone marrow [11, 46]. The gene discussed is SELE; the disease is neoplasm.